Dandelion Root Extract in Patients with Refractory Hematologic Malignancies

Trial Status: Recruiting
Start Date: April, 2013
Expected Enrolment: 30
Type of Trial: Treatment
Protocol IDs: OCT1226, DRE
Trial Design: None specified
Trial Phase: Phase 1
Medical Conditions: None specified
Drugs: N/A
Lead Sponsor: Lotte & John Hecht Memorial Foundation
Sponsors/Study Groups: Lotte & John Hecht Memorial Foundation
Type of Treatment: None specified
Principal Investigator(s): Caroline Hamm, MD, Windsor Regional Cancer Center
Date posted on clinicaltrials.gov: March 5, 2013
Last updated: April 25, 2017

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.

Resources

Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society